原创《新型AhmedFP7FP8青光眼引流阀植入术的临床应用价值》：本文关于青光眼论文范文,可以做为相关论文参考文献,与写作提纲思路参考。
DOI：10.16662/j.cnki.1674-0742.2017.09.052
[摘 要] 目的 探究新型Ahmed FP7/FP8青光眼引流阀植入术在临床的应用价值.方法 便利选取2014年1月—2016年1月于该院接受治疗的70例難治性青光眼青年患者为研究对象.按照随机数表法将70例患者分为观察组和对照组各35例.对照组患者进行常规治疗,观察组接受新型Ahmed FP7/FP8青光眼引流阀植入术治疗,治疗后分别对两组患者眼压、视力、并发症发生率、手术成功率等多项指标进行统计,对比分析结果.结果 观察组出现浅前房、脉络膜脱离、葡萄膜炎反应例数分别为0例、1例、1例,对照组分别为3例、1例、2例；观察组并发症发生率6.2%,明显低于对照组的18.6%,差异有统计学意义（P<0.05）.结论 使用新型Ahmed FP7/FP8青光眼引流阀植入术对难治性青光眼青年进行治疗,能显著降低患者眼压,利于患者视力恢复且手术成功率高,值得广泛应用和推广.
[关键词] 新型Ahmed FP7/FP8；青光眼引流阀植入术；难治性青光眼；效果观察
[中图分类号] R5 [文献标识码] A [文章编号] 1674-0742（2017）03（c）-0052-03
Research on Clinical Application Value of Newly Ahmed FP7/FP8 Glaucoma Valve Implantation
QIN Tao
Department of Ophthalmology, Guigang People’s Hospital, Guigang, Guangxi, 537100 China
[Abstract] Objective To study the clinical application value of newly Ahmed FP7/FP8 glaucoma valve implantation. Methods 70 cases of young patients with refractory neovascular glaucoma treated in our hospital from January 2014 to January 2016 were convenient selected as the research objects and randomly divided into two groups with 35 cases in each, the control group were given the routine treatment, while the observation group were treated with newly Ahmed FP7/FP8 glaucoma valve implantation, and the intraocular pressure, vision, incidence rate of complications and success rate of operation of the two groups were counted after treatment and the analysis results were compared and analyzed. Results The number of cases with shallow anterior chamber, detachment of choroids and uveitis reaction was respectively 0, 1, 1 in the observation group and 3,1,2 in the control group, and the incidence rate of complications in the observation group was obviously lower than that in the control group （6.2% vs 18.6%）, and the difference was statistically significant（P<0.05）. Conclusion The newly Ahmed FP7/FP8 glaucoma valve implantation in treatment of young patients with refractory neovascular glaucoma can obviously decrease the intraocular pressure, which is conducive to vision restoration with high operative success rate, which is worth wide application and promotion.
[Key words] Newly Ahmed FP7/FP8； Glaucoma valve implantation； Refractory neovascular glaucoma； Observation on effect
青光眼是一种十分常见的致盲疾病,近几年来在我国青年人群中发病率呈上升趋势[1].各种类别继发性青光眼,如外伤性、新生血管性、葡萄膜炎性、无晶状体眼青光眼称作“难治性青光眼”,其发病机理复杂,一般采用药物治疗难以达到令人满意的效果[2-3],传统的小梁切除术难以避免浅前房、脉络膜脱离等手术并发症的发生从而导致手术失败[4].Ahmed FP7/FP8青光眼引流阀植入术是一种治疗难治性青光眼的新型技术,该研究便利选取2014年1月—2016年1月于该院接受治疗的70例难治性青光眼患者为研究对象,探究新型Ahmed FP7/FP8青光眼引流阀植入术治疗难治性青光眼青年患者的治疗效果,为临床提供参考依据,现报道如下.
青光眼论文参考资料：
结论：新型AhmedFP7FP8青光眼引流阀植入术的临床应用价值为关于对写作青光眼论文范文与课题研究的大学硕士、相关本科毕业论文青光眼论文开题报告范文和相关文献综述及职称论文参考文献资料下载有帮助。
